Affordable Access

Antiinflammatory effects of soluble complement receptor type 1 promote rapid recovery of ischemia/reperfusion injury in rat small intestine.

Authors
  • Eror, A T
  • Stojadinovic, A
  • Starnes, B W
  • Makrides, S C
  • Tsokos, G C
  • Shea-Donohue, T
Type
Published Article
Journal
Clinical immunology (Orlando, Fla.)
Publication Date
Feb 01, 1999
Volume
90
Issue
2
Pages
266–275
Identifiers
PMID: 10080839
Source
Medline
License
Unknown

Abstract

We examined the effect of soluble complement receptor type 1 (sCR1) on mucosal injury and inflammation in a rat model of ischemia/reperfusion. Groups of vehicle- and sCR1-treated rats underwent 30 min of mesenteric ischemia followed by 60 or 120 min of reperfusion. When compared to vehicle-treated rats, treatment with sCR1 (12 mg/kg) prior to 120 min of reperfusion significantly reduced mucosal injury, neutrophil infiltration, leukotriene B4 production, and restored villus height to control levels. The protective effect of sCR1 evident at 120 min of reperfusion was not observed at 60 min of reperfusion despite rapid inactivation of complement. These data suggest that complement inhibition minimized mucosal disruption by facilitating mucosal restitution or interrupting the inflammatory process. Delayed administration of sCR1 for 30 or 60 min into the reperfusion period progressively reduced the protection. sCR1-mediated rapid recovery of rat intestine after ischemia/reperfusion underscores the fundamental role of complement activation in neutrophil-mediated tissue injury.

Report this publication

Statistics

Seen <100 times